EP Patent

EP2673237B1 — Use of a zirconium silicate for the treatment of hyperkalemia

Assigned to ZS Pharma Inc · Expires 2018-11-07 · 8y expired

What this patent protects

Patent listed against sodium-zirconium-cyclosilicate.

Drugs covered by this patent

sodium-zirconium-cyclosilicate (SODIUM ZIRCONIUM CYCLOSILICATE)

Patent Metadata

Patent number: EP2673237B1
Jurisdiction: EP
Classification: —
Expires: 2018-11-07
Drug substance claim: No
Drug product claim: No
Assignee: ZS Pharma Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.